Neurology India, ISSN 0028-3886, 01/2017, Volume 65, Issue 1, pp. 121 - 122
Journal Article
World Neurosurgery, ISSN 1878-8750, 12/2019
Journal Article
3.
Full Text
Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma
Modern Pathology, ISSN 0893-3952, 10/2010, Volume 23, Issue 10, pp. 1404 - 1417
Malignant astrocytoma includes anaplastic astrocytoma (grade III) and glioblastoma (grade IV). Among them, glioblastoma is the most common primary brain tumor...
MicroRNA | Glioma | Microarray | PAM | Astrocytoma | Glioblastoma | PATHWAYS | CELLS | GLIOBLASTOMA-MULTIFORME | PROLIFERATION | PATHOLOGY | MICRORNA-21 | CANCER | microarray | glioblastoma | astrocytoma | GENE-EXPRESSION | glioma | microRNA | MICROARRAYS | HIGH-GRADE GLIOMA | BRAIN | Astrocytoma - genetics | Immunohistochemistry | Astrocytoma - pathology | Genome-Wide Association Study | MicroRNAs - analysis | Humans | Brain Neoplasms - pathology | Brain Neoplasms - genetics | Biomarkers, Tumor - genetics | Gene Expression Profiling | MicroRNAs - genetics | Reverse Transcriptase Polymerase Chain Reaction
MicroRNA | Glioma | Microarray | PAM | Astrocytoma | Glioblastoma | PATHWAYS | CELLS | GLIOBLASTOMA-MULTIFORME | PROLIFERATION | PATHOLOGY | MICRORNA-21 | CANCER | microarray | glioblastoma | astrocytoma | GENE-EXPRESSION | glioma | microRNA | MICROARRAYS | HIGH-GRADE GLIOMA | BRAIN | Astrocytoma - genetics | Immunohistochemistry | Astrocytoma - pathology | Genome-Wide Association Study | MicroRNAs - analysis | Humans | Brain Neoplasms - pathology | Brain Neoplasms - genetics | Biomarkers, Tumor - genetics | Gene Expression Profiling | MicroRNAs - genetics | Reverse Transcriptase Polymerase Chain Reaction
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 10/2019, Volume 72, Issue 10, pp. 677 - 681
AimsTumour recurrence is inevitable in glioblastoma (GBM) and mostly noted in the peritumoural brain zone (PT). In our previous microarray-based study, we...
Journal Article
5.
Full Text
GENE-51. ROLE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) IN PRIMARY AND RECURRENT GLIOBLASTOMA
Neuro-Oncology, ISSN 1522-8517, 11/2019, Volume 21, Issue Supplement_6, pp. vi108 - vi109
Abstract Glioblastoma (GBM) is the most common primary malignant tumor of the adult central nervous system. It is highly invasive and almost inevitably recurs;...
Journal Article
Neurology India, ISSN 0028-3886, 07/2018, Volume 66, Issue 4, pp. 1115 - 1116
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2013, Volume 8, Issue 5, p. e63164
Glioblastoma is one of the common types of primary brain tumors with a median survival of 12-15 months. The receptor tyrosine kinase (RTK) pathway is known to...
MULTIDISCIPLINARY SCIENCES | MICRORNAS | Mutagenesis, Site-Directed | Humans | 3' Untranslated Regions - genetics | MicroRNAs - metabolism | DNA Primers - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Receptor, Epidermal Growth Factor - metabolism | Receptor Protein-Tyrosine Kinases - genetics | Microarray Analysis | Cell Line, Tumor | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Glioblastoma - metabolism | Signal Transduction - physiology | Colony-Forming Units Assay | Real-Time Polymerase Chain Reaction | Tyrosine | Phenols | Genetic aspects | MicroRNA | Glioblastoma multiforme | Brain tumors | Brain | Biotechnology | Deregulation | Brain cancer | Glioblastoma | Mental health | Genomes | Biology | Neurosurgery | Kinases | Cancer therapies | Proteins | Pathways | Glioma cells | Protein-tyrosine kinase receptors | Inhibition | Protein-tyrosine kinase | Medical research | Epidermal growth factor receptors | MiRNA | MAP kinase | Patients | 1-Phosphatidylinositol 3-kinase | Brain research | 3' Untranslated regions | MicroRNAs | Medical prognosis | Cell lines | Tumor suppressor genes | Mutation | Cell migration | Apoptosis | Tumors
MULTIDISCIPLINARY SCIENCES | MICRORNAS | Mutagenesis, Site-Directed | Humans | 3' Untranslated Regions - genetics | MicroRNAs - metabolism | DNA Primers - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Receptor, Epidermal Growth Factor - metabolism | Receptor Protein-Tyrosine Kinases - genetics | Microarray Analysis | Cell Line, Tumor | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Glioblastoma - metabolism | Signal Transduction - physiology | Colony-Forming Units Assay | Real-Time Polymerase Chain Reaction | Tyrosine | Phenols | Genetic aspects | MicroRNA | Glioblastoma multiforme | Brain tumors | Brain | Biotechnology | Deregulation | Brain cancer | Glioblastoma | Mental health | Genomes | Biology | Neurosurgery | Kinases | Cancer therapies | Proteins | Pathways | Glioma cells | Protein-tyrosine kinase receptors | Inhibition | Protein-tyrosine kinase | Medical research | Epidermal growth factor receptors | MiRNA | MAP kinase | Patients | 1-Phosphatidylinositol 3-kinase | Brain research | 3' Untranslated regions | MicroRNAs | Medical prognosis | Cell lines | Tumor suppressor genes | Mutation | Cell migration | Apoptosis | Tumors
Journal Article
Journal of Neurosciences in Rural Practice, ISSN 0976-3147, 12/2013, Volume 4, Issue S 01, pp. S121 - S124
ABSTRACT Ependymoma is one of the uncommon tumors of the central nervous system (CNS) in the adult age group. These tumors have a distinct propensity for...
Case Report | ependymoma | metastasis | Anaplasia | cerebrospinal fluid | Case studies | Care and treatment | Diagnosis | Metastasis | Research | Gliomas | Spinal cord | Medical imaging | Nuclear magnetic resonance--NMR | Multivariate analysis | Tumors | Aggressiveness | Cerebrospinal fluid | Ependymoma
Case Report | ependymoma | metastasis | Anaplasia | cerebrospinal fluid | Case studies | Care and treatment | Diagnosis | Metastasis | Research | Gliomas | Spinal cord | Medical imaging | Nuclear magnetic resonance--NMR | Multivariate analysis | Tumors | Aggressiveness | Cerebrospinal fluid | Ependymoma
Journal Article
Molecular Cancer, ISSN 1476-4598, 11/2016, Volume 15, Issue 1, p. 74
Background: Glioblastomas (GBM) continue to remain one of the most dreaded tumours that are highly infiltrative in nature and easily preclude comprehensive...
LY294002 | Growth suppression and RNA sequencing | MiR-326 | Glioblastoma | ARRB1 | MiRNome | PI3 kinase pathway | CELLS | PHOSPHORYLATION | PROTEIN-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | miR-326 | CANCER | MICRORNA CONTROL | BRAIN-TUMORS | miRNome | BIOGENESIS | ONCOLOGY | LEUKEMIA | PROMOTER | EXPRESSION | Computational Biology - methods | Signal Transduction | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Brain Neoplasms - genetics | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Brain Neoplasms - metabolism | Phosphatidylinositol 3-Kinases - genetics | Glioblastoma - genetics | RNA Interference | beta-Arrestin 1 - genetics | Cell Transformation, Neoplastic - genetics | Cell Line, Tumor | Glioblastoma - metabolism | MicroRNAs - genetics | Genes, Tumor Suppressor | Gene Ontology | Cluster Analysis | MicroRNA | Physiological aspects | Development and progression | Tumor suppressor genes | Genetic aspects | Research | Glioblastoma multiforme
LY294002 | Growth suppression and RNA sequencing | MiR-326 | Glioblastoma | ARRB1 | MiRNome | PI3 kinase pathway | CELLS | PHOSPHORYLATION | PROTEIN-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | miR-326 | CANCER | MICRORNA CONTROL | BRAIN-TUMORS | miRNome | BIOGENESIS | ONCOLOGY | LEUKEMIA | PROMOTER | EXPRESSION | Computational Biology - methods | Signal Transduction | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Brain Neoplasms - genetics | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Brain Neoplasms - metabolism | Phosphatidylinositol 3-Kinases - genetics | Glioblastoma - genetics | RNA Interference | beta-Arrestin 1 - genetics | Cell Transformation, Neoplastic - genetics | Cell Line, Tumor | Glioblastoma - metabolism | MicroRNAs - genetics | Genes, Tumor Suppressor | Gene Ontology | Cluster Analysis | MicroRNA | Physiological aspects | Development and progression | Tumor suppressor genes | Genetic aspects | Research | Glioblastoma multiforme
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 02/2019, Volume 9, Issue 1, pp. 2749 - 12
Despite advances in biology and treatment modalities, the prognosis of glioblastoma (GBM) remains poor. Serum reflects disease macroenvironment and thus...
SURVIVAL | PLASMA-LEVELS | MARKER | PURITY | MULTIDISCIPLINARY SCIENCES | TISSUE | S100 PROTEIN FAMILY | S100A8/A9 | SUPPRESSOR-CELLS | YKL-40 | EXPRESSION | Prognosis | Transcription | Medical prognosis | Glioma cells | Glioblastoma | Stroma | Cell lineage | Quantitation | Cell migration | Enzyme-linked immunosorbent assay | Cell adhesion & migration
SURVIVAL | PLASMA-LEVELS | MARKER | PURITY | MULTIDISCIPLINARY SCIENCES | TISSUE | S100 PROTEIN FAMILY | S100A8/A9 | SUPPRESSOR-CELLS | YKL-40 | EXPRESSION | Prognosis | Transcription | Medical prognosis | Glioma cells | Glioblastoma | Stroma | Cell lineage | Quantitation | Cell migration | Enzyme-linked immunosorbent assay | Cell adhesion & migration
Journal Article
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, p. e0215400
Objective To assess the inter-technique agreement of relative cerebral blood volume (rCBV) measurements obtained using T1-and T2*-perfusion MRI on 3T scanner...
PERFUSION MRI | CONTRAST-ENHANCED MRI | TUMOR RECURRENCE | PERMEABILITY | GRADE GLIOMAS | MULTIDISCIPLINARY SCIENCES | INPUT FUNCTION | RECURRENT GLIOBLASTOMA | BLOOD-VOLUME | DIAGNOSTIC-ACCURACY | BRAIN GLIOMAS | Medicine, Experimental | Medical research | Magnetic resonance imaging | Comparative analysis | Gliomas | Brain tumors | Research | Analysis | Cerebral circulation | Brain | Neurosciences | Brain cancer | Correlation coefficients | Medical diagnosis | Hemorrhage | Blood | Accuracy | Blood volume | Cerebral blood flow | Qualitative analysis | Lesions | Quantitative analysis | Correlation coefficient | Evaluation | Statistical analysis | Medical imaging | Observers | Permeability | Glioma | Perfusion | Diagnostic systems | Hemodynamics | Gene mapping | Tumors
PERFUSION MRI | CONTRAST-ENHANCED MRI | TUMOR RECURRENCE | PERMEABILITY | GRADE GLIOMAS | MULTIDISCIPLINARY SCIENCES | INPUT FUNCTION | RECURRENT GLIOBLASTOMA | BLOOD-VOLUME | DIAGNOSTIC-ACCURACY | BRAIN GLIOMAS | Medicine, Experimental | Medical research | Magnetic resonance imaging | Comparative analysis | Gliomas | Brain tumors | Research | Analysis | Cerebral circulation | Brain | Neurosciences | Brain cancer | Correlation coefficients | Medical diagnosis | Hemorrhage | Blood | Accuracy | Blood volume | Cerebral blood flow | Qualitative analysis | Lesions | Quantitative analysis | Correlation coefficient | Evaluation | Statistical analysis | Medical imaging | Observers | Permeability | Glioma | Perfusion | Diagnostic systems | Hemodynamics | Gene mapping | Tumors
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 1/2019, Volume 141, Issue 2, pp. 315 - 325
Peritumoural brain zone (PT) of glioblastoma (GBM) is the area where tumour recurrence is often observed. We aimed to identify differentially regulated genes...
Neurology | Recurrence | GBM | Medicine & Public Health | PBK | Oncology | Peritumoural brain zone | Gene expression profile | INITIATING CELLS | SURVIVAL | ANGIOGENESIS | PHENOTYPE | SUPPRESSION | CLINICAL NEUROLOGY | GENE | ONCOLOGY | POOR-PROGNOSIS | PROSTATE-CANCER | EXPRESSION | PBK/TOPK | Cell proliferation | DNA microarrays | Glioblastoma | Chemoresistance | Data processing | Temozolomide | Gene expression | Kinases | Cell migration | Tumors
Neurology | Recurrence | GBM | Medicine & Public Health | PBK | Oncology | Peritumoural brain zone | Gene expression profile | INITIATING CELLS | SURVIVAL | ANGIOGENESIS | PHENOTYPE | SUPPRESSION | CLINICAL NEUROLOGY | GENE | ONCOLOGY | POOR-PROGNOSIS | PROSTATE-CANCER | EXPRESSION | PBK/TOPK | Cell proliferation | DNA microarrays | Glioblastoma | Chemoresistance | Data processing | Temozolomide | Gene expression | Kinases | Cell migration | Tumors
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 04/2018, Volume 71, Issue 4, pp. 323 - 329
AimsThe WHO 2016 classification of diffuse gliomas combines histological and molecular parameters for diagnosis. However, in view of cost constraints for...
resource constraint | integrated diagnosis | algorithmic approach | diffuse glioma | ASTROCYTOMA | TERT PROMOTER MUTATIONS | OLIGODENDROGLIOMA | PROGNOSTIC-FACTORS | ATRX | PATHOLOGY | IDH | TUMORS | LOW-GRADE | Isocitrate Dehydrogenase - biosynthesis | Glioma - classification | Biomarkers, Tumor - analysis | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Immunohistochemistry - methods | Young Adult | Algorithms | X-linked Nuclear Protein - biosynthesis | Brain Neoplasms - classification | Glioma - pathology | Isocitrate Dehydrogenase - analysis | Adult | Female | Aged | X-linked Nuclear Protein - analysis | Automation | Laboratories | Neuropathology | Medical prognosis | Brain cancer | Classification | Nervous system | Histology | Mutation | Medical diagnosis | Tumors
resource constraint | integrated diagnosis | algorithmic approach | diffuse glioma | ASTROCYTOMA | TERT PROMOTER MUTATIONS | OLIGODENDROGLIOMA | PROGNOSTIC-FACTORS | ATRX | PATHOLOGY | IDH | TUMORS | LOW-GRADE | Isocitrate Dehydrogenase - biosynthesis | Glioma - classification | Biomarkers, Tumor - analysis | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Immunohistochemistry - methods | Young Adult | Algorithms | X-linked Nuclear Protein - biosynthesis | Brain Neoplasms - classification | Glioma - pathology | Isocitrate Dehydrogenase - analysis | Adult | Female | Aged | X-linked Nuclear Protein - analysis | Automation | Laboratories | Neuropathology | Medical prognosis | Brain cancer | Classification | Nervous system | Histology | Mutation | Medical diagnosis | Tumors
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 08/2016, Volume 69, Issue 8, pp. 686 - 694
AimsAnaplastic gliomas (AGs; WHO Grade III) include anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA) and...
SURVIVAL | IDH1 MUTATIONS | MGMT PROMOTER METHYLATION | MALIGNANT GLIOMAS | CLASSIFICATION | OLIGODENDROGLIAL TUMORS | PATHOLOGY | MOLECULAR DIAGNOSTICS | CHEMOTHERAPY | BRAIN-TUMORS | 1P/19Q LOSS | Prognosis | Humans | Middle Aged | Oligodendroglioma - diagnosis | Brain Neoplasms - pathology | Male | X-linked Nuclear Protein | Brain Neoplasms - metabolism | Young Adult | Astrocytoma - pathology | DNA Repair Enzymes - metabolism | Oligodendroglioma - metabolism | Adult | Female | Brain Neoplasms - mortality | Astrocytoma - diagnosis | Astrocytoma - mortality | Astrocytoma - metabolism | Oligodendroglioma - mortality | Promoter Regions, Genetic | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Brain Neoplasms - diagnosis | Nuclear Proteins - metabolism | Survival Rate | DNA Helicases - metabolism | Oligodendroglioma - pathology | Isocitrate Dehydrogenase - metabolism
SURVIVAL | IDH1 MUTATIONS | MGMT PROMOTER METHYLATION | MALIGNANT GLIOMAS | CLASSIFICATION | OLIGODENDROGLIAL TUMORS | PATHOLOGY | MOLECULAR DIAGNOSTICS | CHEMOTHERAPY | BRAIN-TUMORS | 1P/19Q LOSS | Prognosis | Humans | Middle Aged | Oligodendroglioma - diagnosis | Brain Neoplasms - pathology | Male | X-linked Nuclear Protein | Brain Neoplasms - metabolism | Young Adult | Astrocytoma - pathology | DNA Repair Enzymes - metabolism | Oligodendroglioma - metabolism | Adult | Female | Brain Neoplasms - mortality | Astrocytoma - diagnosis | Astrocytoma - mortality | Astrocytoma - metabolism | Oligodendroglioma - mortality | Promoter Regions, Genetic | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Brain Neoplasms - diagnosis | Nuclear Proteins - metabolism | Survival Rate | DNA Helicases - metabolism | Oligodendroglioma - pathology | Isocitrate Dehydrogenase - metabolism
Journal Article
Neuropathology, ISSN 0919-6544, 04/2019, Volume 39, Issue 2, pp. 78 - 84
Adult thalamic glioblastomas (GBM) are uncommon tumors with limited available molecular data. One of the reported molecular alterations in these tumors is the...
GBM | thalamic | adult | immunopositivity | H3K27M | MOLECULAR SUBGROUPS | MUTATIONS | PATHOLOGY | BRAIN-STEM GLIOMAS | NEUROSCIENCES | CLINICAL NEUROLOGY | Adults | Biological products | Tumor proteins | Methylation | Analysis | Immunohistochemistry | RNA-directed DNA polymerase | Telomerase reverse transcriptase | Epidermal growth factor receptors | p53 Protein | Methylguanine | Glioblastoma | Thalassemia | O6-methylguanine-DNA methyltransferase | Epidermal growth factor | Older people | DNA methylation | DNA methyltransferase | Thalamus | Decompression | Mutation | Isocitrate dehydrogenase | Telomerase | Tumors
GBM | thalamic | adult | immunopositivity | H3K27M | MOLECULAR SUBGROUPS | MUTATIONS | PATHOLOGY | BRAIN-STEM GLIOMAS | NEUROSCIENCES | CLINICAL NEUROLOGY | Adults | Biological products | Tumor proteins | Methylation | Analysis | Immunohistochemistry | RNA-directed DNA polymerase | Telomerase reverse transcriptase | Epidermal growth factor receptors | p53 Protein | Methylguanine | Glioblastoma | Thalassemia | O6-methylguanine-DNA methyltransferase | Epidermal growth factor | Older people | DNA methylation | DNA methyltransferase | Thalamus | Decompression | Mutation | Isocitrate dehydrogenase | Telomerase | Tumors
Journal Article
Scientific Reports, ISSN 2045-2322, 06/2016, Volume 6, Issue 1, p. 27753
Glioblastomas (GBM) are the most malignant form of astrocytomas which are difficult to treat and portend a grave clinical course and poor prognosis. In this...
CHROMOBOX PROTEIN | POLYCOMB GROUP PROTEINS | TISSUE GROWTH-FACTOR | MULTIDISCIPLINARY SCIENCES | EMBRYONIC STEM-CELLS | MOLECULAR PATHOLOGY | HIPPO PATHWAY | TUMOR-SUPPRESSOR | PROLIFERATION | EXPRESSION | HUMAN CANCER
CHROMOBOX PROTEIN | POLYCOMB GROUP PROTEINS | TISSUE GROWTH-FACTOR | MULTIDISCIPLINARY SCIENCES | EMBRYONIC STEM-CELLS | MOLECULAR PATHOLOGY | HIPPO PATHWAY | TUMOR-SUPPRESSOR | PROLIFERATION | EXPRESSION | HUMAN CANCER
Journal Article